Bipartisan U.S. House Members Corralling Last-Minute Signatures on 340B Letter to HHS
Today is the deadline for U.S. House members to sign a bipartisan letter asking U.S. Health and Human Services Department (HHS) leaders to act against drug manufacturers denying 340B pricing on drugs, to halt attempts to turn 340B into a rebate program, and to seat the 340B administrative dispute resolution board immediately and begin processing petitions. The original deadline was Feb. 11.